Biosyntia Overview
- Year Founded
-
2012

- Status
-
Private
- Employees
-
21

- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$17.3M
- Investors
-
11
Biosyntia General Information
Description
Developer of a fermentation-based platform intended to produce natural active ingredients for various applications. The company offers a proprietary process that utilizes unique microorganisms to create high-purity vitamins and bioactives, minimizing environmental impact through reduced chemical waste and land use, enabling businesses in the nutraceutical and personal care sectors to meet consumer demand for sustainable products while ensuring quality and traceability.
Contact Information
Website
www.biosyntia.comCorporate Office
- Fruebjergvej 3, boks 54
- 2100 Copenhagen
- Denmark
Corporate Office
- Fruebjergvej 3, boks 54
- 2100 Copenhagen
- Denmark
Biosyntia Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Later Stage VC (Series B) | 30-Sep-2022 | $17.3M | Completed | Generating Revenue | ||
6. Later Stage VC (Series A) | 23-May-2018 | Completed | Generating Revenue | |||
5. Seed Round | 21-May-2015 | Completed | Generating Revenue | |||
4. Grant | 01-Dec-2013 | Completed | Startup | |||
3. Grant | 01-Jun-2013 | Completed | Startup | |||
2. Grant | 01-Nov-2012 | $145K | Completed | Startup | ||
1. University Spin-Out | 01-Jan-2012 | Completed | Startup |
Biosyntia Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | 39,297 | $23.74 | $23.74 | 1x | $23.74 | 4.9% | ||
Ordinary | 29,333 | $24.99 | $24.99 | 1x | $24.99 | 3.66% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Biosyntia Comparisons
Industry
Financing
Details
Biosyntia Competitors (13)
One of Biosyntia’s 13 competitors is DMC (Biotechnology), a Venture Capital-Backed company based in Boulder, CO.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
DMC (Biotechnology) | Venture Capital-Backed | Boulder, CO | ||||
Geno (Biotechnology) | Venture Capital-Backed | San Diego, CA | ||||
Lygos | Venture Capital-Backed | Hayward, CA | ||||
Codexis | Formerly VC-backed | Redwood City, CA | ||||
P e G Supermercados - Garopaba | Corporation | Garopaba, Brazil |
Biosyntia Patents
Biosyntia Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4370653-A2 | Microbial cell factories producing vitamin b compounds | Pending | 16-Jul-2021 | ||
US-20240368659-A1 | Microbial cell factories producing vitamin b compounds | Pending | 16-Jul-2021 | ||
EP-4168566-A1 | Methods for producing biotin in genetically modified microorganisms | Pending | 18-Jun-2020 | ||
US-20220127311-A1 | Cell factories for improved production of compounds and proteins dependent on iron sulfur clusters | Pending | 16-Jan-2019 | ||
EP-3911666-A1 | Cell factories for improved production of compounds and proteins dependent on iron sulfur clusters | Pending | 16-Jan-2019 | C07K14/245 |
Biosyntia Signals
Biosyntia Investors (11)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Denmark's Export and Investment Fund | Venture Capital | Minority | ||
ECBF Management | Venture Capital | Minority | ||
Praesidium (Luxembourg) | Asset Manager | Minority | ||
Sofinnova Partners | Venture Capital | Minority | ||
European Union Seventh Framework Programme | Government |
Biosyntia FAQs
-
When was Biosyntia founded?
Biosyntia was founded in 2012.
-
Where is Biosyntia headquartered?
Biosyntia is headquartered in Copenhagen, Denmark.
-
What is the size of Biosyntia?
Biosyntia has 21 total employees.
-
What industry is Biosyntia in?
Biosyntia’s primary industry is Biotechnology.
-
Is Biosyntia a private or public company?
Biosyntia is a Private company.
-
What is the current valuation of Biosyntia?
The current valuation of Biosyntia is
. -
What is Biosyntia’s current revenue?
The current revenue for Biosyntia is
. -
How much funding has Biosyntia raised over time?
Biosyntia has raised $24M.
-
Who are Biosyntia’s investors?
Denmark's Export and Investment Fund, ECBF Management, Praesidium (Luxembourg), Sofinnova Partners, and European Union Seventh Framework Programme are 5 of 11 investors who have invested in Biosyntia.
-
Who are Biosyntia’s competitors?
DMC (Biotechnology), Geno (Biotechnology), Lygos, Codexis, and P e G Supermercados - Garopaba are some of the 13 competitors of Biosyntia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »